The purpose of this study was to investigate the reappearance of the post-absorptive resting metabolic rate (PARM) during a prescribed diet. The subjects were 10 sedentary female college students (20.1±0.7yrs) . Thyroid function was judged in all of them to be within a normal range. Subjects stayed in a metabolic ward at the National Institute of Health and Nutrition for 18 days. The post-absorptive resting metabolic rate was measured 4 times during the experimental period. Moreover, blood was collected five times, and general health care including the measurement of thyroxin by blood biochemical examination was carried out. As for the actual metabolic measurements, a high reappearance was confirmed by the intra-individual coefficient of variation (CV) of the post-absorptive resting metabolic rate (3.5±1.8%) and the inter-individual CV (7.2%) . The smallest CV was the standard value of PARM/body surface area, followed by PARM/body weight, PARM/LBM, and PARM/urine creatinine. On the other hand, weight (50.8±4.9 vs 50.3±4.6 kg ; p<0.01), hemoglobin concentration (13.7 ± 0.5 vs 12.8±0.5g/dl ; p<0.05), serum total cholesterol level (194±41 vs 175 ± 37 mg/dl ; p<0.05) and post-absorptive resting oxygen uptake (0.149±0.01 vs 0.142±0.011/min ; p<0.01) decreased significantly during the experiment. According to the Japanese Recommended Dietary Allowances (RDAs) (1999), basal metabolic rate (BMR) was calculated at 1, 210 kcal/day or 23.6 kcal/kg body weight/day for women within the 18-29 year age group. But the results (the mean of all measurements) of this research suggested that this value was 1, 033 ± 79 kcal/day, or 20.7 ± 2.0 kcal/kg body weight/day based on the method of Weir ; and was approximately 10% lower than RDAs. Future investigation is required to explain the reasons for the difference in BMR between this study and that of previous ones.

The purpose of this study was to investigate the effect of changes in post-absorptive resting metabolism (PARM) on plasma triiodothyronine (T3) levels under a prescribed diet. The subjects were 31 sedentary female college students (19.9±0.9 yrs). Subjects stayed in a metabolic ward at the National Institute of Health and Nutrition for 18 days. PARM was measured 4 times during the experimental period. Additionally, blood was collected 4 times during the experimental period, and general health care including the measurement of thyroxin by blood biochemical examination was carried out. Subjects were divided into three groups (n=26, n=4, n=1), two of which were analyzed for this study. The two groups were divided according to thyroid function: Group N (n=26) included subjects in which T3 was judged to be within the normal range during the experimental period; Group L (n=4) included subjects for whom T3 was not normal during the study period, and was judged to be under the normal range at least once. The remaining 1 subject had a T3 judged to be over the normal range.For Group N, several parameters decreased significantly during the course of the experiment: weight was 51.5±4.97 vs. 50.8±4.3 kg (p<0.01); T3 was 1.16±0.19 vs. 1.01±0.12 ng/ml (p<0.01); and PARM was 3.1±0.2 vs. 2.9±0.2 ml/min/kg (p<0.05). For Group L, several parameters also decreased significantly during the course of the experiment: weight was 53.6±4.9 vs. 52.6±4.5 kg (p<0.01); T3 was 0.94±0.15 vs. 0.75±0.07 ng/ml (p<0.01); and PARM was 2.9±0.2 vs. 2.7±0.1 ml/min/kg (p<0.05). The average PARM of Group N was significantly higher than that of Group L (7.0%). PARM during the luteal phase of the menstrual cycle was significantly higher than during the menstrual phase (3.5 %), in subjects for whom the phases of the menstrual cycle were distinguishable (n=13).According to the 2005 Dietary Reference Intakes (DRIs) for Japanese, the basal metabolic rate (BMR) is calculated at 23.6 kcal/kg body weight/day, or 3.27 ml/min/kg translated for VO₂ for women within the 18~29 year age group. However, the values calculated from the measurements of this research study were approximately 9.5% lower for Group N and 15.8% lower for Group L than that of the DRIs.Future investigation is required to explain the reasons for the difference in PARM between this study and that of previous ones.

The patient was a 73-year-old woman. She had been treated for squamous cell carcinoma of the lung (cT3N3M0, Stage IIIC) at our department. The patient had low back pain due to retroperitoneal lymph node metastasis; in June 2022, this was exacerbated as lung cancer progressed. She had difficulty in body movements due to edema in both lower limbs, in addition to the pain. Consequently, she was urgently admitted on July 8 and received radiotherapy (30 Gy/10 fractions) for retroperitoneal lymph node metastasis. She was being given tapentadol at a dose of 200 mg/day for relief of her pain. However, she was switched to fentanyl patch at a dose of 1200 µg/day during her hospitalization, which resulted in relief of low back pain. The underlying disease causing the edema was investigated. Based on physical and laboratory findings and medical history, lymphedema associated with retroperitoneal lymph node metastases was diagnosed. On day 31 of hospitalization, the patient was allowed to be temporarily discharged from the hospital because the edema had improved and the activity of daily living around the bed had increased. Treatment methods for lymphedema associated with lymph node metastasis have not been established, but the efficacy of radiotherapy has been reported. We have herein reported a case of lymphedema that was improved by radiotherapy after it was differentiated from other diagnoses.